» Journals » Chin J Cancer Res

Chinese Journal of Cancer Research

Chinese Journal of Cancer Research is a scientific journal, published since 1988 in English. The journal's country of origin is China and its primary focus area is oncology.

Details
Abbr. Chin J Cancer Res
Start 1988
End Continuing
Frequency Quarterly
p-ISSN 1000-9604
e-ISSN 1993-0631
Country China
Language English
Specialty Oncology
Recent Articles
11.
Li J, Ping P, Li Y, Xu X
Chin J Cancer Res . 2025 Jan; 36(6):652-668. PMID: 39802901
Lipid metabolic reprogramming is considered one of the most prominent metabolic abnormalities in cancer, and fatty acid metabolism is a key aspect of lipid metabolism. Recent studies have shown that...
12.
Wang J, He S, Cao M, Teng Y, Li Q, Tan N, et al.
Chin J Cancer Res . 2025 Jan; 36(6):752-767. PMID: 39802900
Objective: Data on the global, regional and national changes in the trends of colorectal cancer (CRC) are analyzed to understand the trends in its burden, in order to assist policymakers...
13.
Ren Y, Gong Y, Zhao H, You D, Li Z, Wang S, et al.
Chin J Cancer Res . 2025 Jan; 36(6):669-682. PMID: 39802899
Gastric cancer (GC) ranks 3rd in incidence rate and mortality rate among malignant tumors in China, and the age-standardized five-year net survival rate of patients with GC was 35.9% from...
14.
Wei J, Bu Z
Chin J Cancer Res . 2025 Jan; 36(6):592-595. PMID: 39802898
No abstract available.
15.
Zhai Y, Liang X, Deng M
Chin J Cancer Res . 2025 Jan; 36(6):616-651. PMID: 39802897
Exhausted T cell (Tex) is a specific state of T cell dysfunction, in which these T cells gradually lose their effector function and change their phenotype during chronic antigen stimulation....
16.
Zong Z, Zeng W, Li Y, Wang M, Cao Y, Cheng X, et al.
Chin J Cancer Res . 2025 Jan; 36(6):683-699. PMID: 39802896
As a key component of tumor microenvironment, the microbiota has gradually played a key role in cancer research. Particularly in colorectal cancer, the specific population of microbiota within the tumor...
17.
Gui L, Chen X, Zhang W, Xie Z, Zhang Y, Li W, et al.
Chin J Cancer Res . 2025 Jan; 36(6):713-728. PMID: 39802895
Objective: Based on the findings of the KEYNOTE-048 study, pembrolizumab in combination with platinum and fluorouracil is the standard first-line treatment for recurrent or metastatic head and neck squamous cell...
18.
Wang Y, Xu B
Chin J Cancer Res . 2025 Jan; 36(6):587-591. PMID: 39802894
No abstract available.
19.
Tian R, Li J, Huang F, Cheng P, Bao M, Zhao L, et al.
Chin J Cancer Res . 2025 Jan; 36(6):768-780. PMID: 39802893
Objective: Colorectal cancer (CRC) surgeries can be performed using either laparoscopic or open laparotomy approaches. However, the long-term outcomes based on tumor location and age remain unclear. This study compared...
20.
Lu Y, Zhu S, Wu C, Fei X, Shen K, Chen X
Chin J Cancer Res . 2025 Jan; 36(6):729-741. PMID: 39802892
Objective: To explore the prognosis-predictive influence of human epidermal growth factor receptor 2 (HER2)-low status in breast cancer patients after neoadjuvant therapy (NAT). Methods: Consecutive patients with invasive breast cancer...